pharmaceutical compliance – Pharma GMP

How to Handle a 483 Observation Without Panic

digi — Thu, 04 Sep 2025 22:11:34 +0000

How to Handle a 483 Observation Without Panic Effective Strategies to Handle FDA 483 Observations Calmly and Confidently Introduction: Why This Topic Matters for GMP Compliance During FDA inspections, investigators document potential violations of current Good Manufacturing Practice (cGMP) on Form 483. Receiving a 483 can be stressful for pharmaceutical manufacturers, but it is not...

Preparing for a Surprise FDA Inspection: Complete SOP

digi — Thu, 04 Sep 2025 04:07:32 +0000

Preparing for a Surprise FDA Inspection: Complete SOP Comprehensive SOP for Handling Surprise FDA Inspections Introduction: Why This Topic Matters for GMP Compliance FDA inspections are designed to ensure that pharmaceutical manufacturers consistently comply with Good Manufacturing Practices (GMP). While some inspections are pre-announced, many are unannounced or “surprise” inspections. These inspections test a company’s...

Real-Life Case Studies of GMP Failure in Indian Pharma

digi — Tue, 02 Sep 2025 13:11:44 +0000

Real-Life Case Studies of GMP Failure in Indian Pharma Case Studies Highlighting GMP Failures in Indian Pharmaceutical Companies Introduction: Why This Topic Matters for GMP Compliance India is one of the largest global suppliers of generic medicines, accounting for a significant share of the pharmaceutical exports to regulated markets such as the United States, the...

Top 10 GMP Violations Cited in USFDA Warning Letters

digi — Mon, 01 Sep 2025 22:15:00 +0000

Top 10 GMP Violations Cited in USFDA Warning Letters Most Frequent GMP Violations Highlighted in USFDA Warning Letters Introduction: Why This Topic Matters for GMP Compliance The United States Food and Drug Administration (USFDA) inspects pharmaceutical facilities worldwide to verify compliance with current Good Manufacturing Practices (cGMP). When critical deficiencies are found, the agency issues...

Protect Critical GMP Documentation from Sunlight and Moisture Exposure

digi — Fri, 22 Aug 2025 22:05:25 +0000

Protect Critical GMP Documentation from Sunlight and Moisture Exposure Shield Critical GMP Documents from Sunlight and Moisture Damage Remember: Never expose GMP records to direct sunlight or moisture — this threatens legibility, traceability, and long-term compliance. Why This Matters in GMP GMP documentation — including SOPs, batch records, logbooks, analytical reports, and calibration certificates —...

Introduction to Global GMP Inspection Models and Harmonization Initiatives

digi — Mon, 19 May 2025 14:03:00 +0000

Introduction to Global GMP Inspection Models and Harmonization Initiatives Understanding International GMP Inspection Models and Global Harmonization Efforts Global pharmaceutical manufacturing is governed by diverse regulatory requirements. Each jurisdiction mandates GMP compliance to ensure drug safety, quality, and efficacy. However, these regulations often differ in execution, terminology, and inspection protocols, making cross-border compliance a significant...